全文获取类型
收费全文 | 1355篇 |
免费 | 92篇 |
国内免费 | 17篇 |
专业分类
儿科学 | 21篇 |
妇产科学 | 2篇 |
基础医学 | 59篇 |
临床医学 | 57篇 |
内科学 | 778篇 |
皮肤病学 | 5篇 |
神经病学 | 4篇 |
特种医学 | 30篇 |
外国民族医学 | 4篇 |
外科学 | 50篇 |
综合类 | 102篇 |
现状与发展 | 1篇 |
预防医学 | 159篇 |
药学 | 101篇 |
中国医学 | 76篇 |
肿瘤学 | 15篇 |
出版年
2024年 | 8篇 |
2023年 | 85篇 |
2022年 | 114篇 |
2021年 | 133篇 |
2020年 | 116篇 |
2019年 | 138篇 |
2018年 | 101篇 |
2017年 | 73篇 |
2016年 | 71篇 |
2015年 | 39篇 |
2014年 | 149篇 |
2013年 | 86篇 |
2012年 | 56篇 |
2011年 | 81篇 |
2010年 | 32篇 |
2009年 | 36篇 |
2008年 | 51篇 |
2007年 | 43篇 |
2006年 | 20篇 |
2005年 | 18篇 |
2004年 | 3篇 |
2003年 | 7篇 |
2002年 | 4篇 |
排序方式: 共有1464条查询结果,搜索用时 15 毫秒
81.
The effect of low volume sprint interval training in patients with non-alcoholic fatty liver disease
Objectives: Exercise is an important part of disease management in patients with non-alcoholic fatty liver disease (NAFLD), but adherence to current exercise recommendations is poor. Novel low-volume sprint interval training (SIT) protocols with total training time commitments of ≤30 min per week have been shown to improve cardiometabolic risk and functional capacity in healthy sedentary participants, but the efficacy of such protocols in the management of NAFLD remains unknown. The aim of the present study was to examine whether a low-volume SIT protocol can be used to improve liver function, insulin resistance, body composition, physical fitness, cognitive function and general well-being in patients with NAFLD.Methods: In the present study, 7 men and 2 women with NAFLD (age: 45 ± 8 y, BMI: 28.7 ± 4.1 kg·m?2) completed a 6-week control period followed by 6 weeks of twice-weekly SIT sessions (5–10 × 6-s ‘all-out’ cycle sprints). Body composition, blood pressure, liver function, metabolic function, functional capacity, cognitive function and quality of life were assessed at baseline, following the control period, and following the SIT intervention.Results: Walking speed during the walk test (+12%), estimated V?O2max (+8%), verbal fluency (+44%), and blood platelet count (+12%; all p < 0.05) significantly increased during the control period. These measures remained significantly raised compared to baseline following the SIT intervention, but did not significantly change any further compared to the post-control time-point. Diastolic blood pressure decreased from 87 ± 10 to 77 ± 8 mm Hg from the end of the control period to the end of the SIT intervention (p < 0.05).Conclusion: This study does not support the use of 6 weeks of a low volume SIT protocol involving twice-weekly sessions with 5–10 × 6-s ‘all-out’ cycle sprints as an intervention for NAFLD disease management. 相似文献
82.
83.
84.
85.
The Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups 下载免费PDF全文
Shiv Chitturi Vincent Wai‐Sun Wong Wah‐Kheong Chan Grace Lai‐Hung Wong Simon Kin‐Hung Wong Jose Sollano Yen‐Hsuan Ni Chun‐Jen Liu Yu‐Cheng Lin Laurentius Adrianto Lesmana Seung Up Kim Etsuko Hashimoto Masahide Hamaguchi Khean‐Lee Goh Jiangao Fan Ajay Duseja Yock Young Dan Yogesh Chawla Geoff Farrell Henry Lik‐Yuen Chan 《Journal of gastroenterology and hepatology》2018,33(1):86-98
86.
Salvatore Petta Giada Sebastiani Elisabetta Bugianesi Mauro Viganò Vincent Wai-Sun Wong Annalisa Berzigotti Anna Ludovica Fracanzani Quentin M. Anstee Fabio Marra Marco Barbara Vincenza Calvaruso Calogero Cammà Vito Di Marco Antonio Craxì Victor de Ledinghen 《Journal of hepatology》2018,68(4):878-885
87.
Kevin Zhe-Yang Xu Chenchen Zhu Moon Sun Kim Johji Yamahara Yuhao Li 《Journal of ethnopharmacology》2009
Aims of the study
Fatty liver is the most common cause of abnormal liver function tests. We investigated the effect and its underlying mechanism of pomegranate flower (PGF), a traditional antidiabetic medicine, on fatty liver.Materials and methods
At the endpoint of treatment of male Zucker diabetic fatty (ZDF) rats with PGF extract (500 mg/kg, p.o. × 6 weeks), liver weight index, hepatic lipid contents (enzymatic colorimetric methods) and droplet accumulation (Oil Red O staining) were determined. Gene profiles (RT-PCR) were analyzed in the liver of ZDF rats and in human liver-derived HepG2 cell line.Results
PGF-treated ZDF rats showed reduced ratio of liver weight to tibia length, hepatic triglyceride contents and lipid droplets. These effects were accompanied by enhanced hepatic gene expression of peroxisome proliferator-activated receptor (PPAR)-alpha, carnitine palmitoyltransferase-1 and acyl-CoA oxidase (ACO), and reduced stearoyl-CoA desaturase-1. In contrast, PGF showed minimal effects on expression of genes responsible for synthesis, hydrolysis or uptake of fatty acid and triglycerides. PGF treatment also increased PPAR-alpha and ACO mRNA levels in HepG2 cells.Conclusion
Our findings suggest that this Unani medicine ameliorates diabetes and obesity-associated fatty liver, at least in part, by activating hepatic expression of genes responsible for fatty acid oxidation. 相似文献88.
芹菜素对非酒精性脂肪肝大鼠的保护作用研究 总被引:1,自引:0,他引:1
目的:芹菜素(Apigenin,AP)对非酒精性脂肪肝(NAFLD)模型大鼠保护作用的初步探讨。方法:采用高脂饲料复制大鼠非酒精性脂肪肝(NAFLD)模型,100只雄性sD大鼠分为6组:正常组、模型组、易善复组、芹菜素高、中、低剂量组,10周后处死所有动物,检测各组大鼠血清ALT、AST、TG、TC、TNF-α以及肝组织SOD、MDA等指标水平。结果:与模型组相比,芹菜素高、中、低剂量组和易善复组能明显降低升高的ALT、AST、TG、TC、TNF—α水平和肝组织的MDA指标水平,而使肝组织SOD活性增强,差异具有显著性意义(P〈0.05或P〈0.01)。结论:芹菜素对高脂饮食诱导的非酒精性脂肪肝(NAFLD)模型大鼠具有一定的保护作用,其作用机理可能与抗脂质过氧化反应、清除体内自由基,减轻炎症介质等水平有关。 相似文献
89.
Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver‐related morbidity; its prevalence is elevating due to the rising epidemic of obesity. Several clinical trials have examined the effects of curcumin supplementation on anthropometric variables in NAFLD patients with inconclusive results. This dose–response meta‐analysis aimed to evaluate the impact of curcumin supplementation on body mass index (BMI), body weight, and waist circumference (WC) in patients with NAFLD. A systematic review of the literature was conducted using PubMed/Medline, ISI Web of Science, Scopus, Cochrane Library, EMBASE, Google Scholar, Sid.ir, and Magiran.com to identify eligible studies up to March 2019. A meta‐analysis of eligible studies was performed using the random‐effects model to estimate the pooled effect size. Eight randomized controlled trials with 520 participants (curcumin group = 265 and placebo group = 255) were included. Supplementation dose and duration ranged from 70 to 3,000 mg/day and 8 to 12 weeks, respectively. Curcumin supplementation significantly reduced BMI (weighted mean difference [WMD] = ?0.34 kg/m2, 95% CI [?0.64, ?0.04], p < .05) and WC (WMD = ?2.12 cm, 95% CI [?3.26, ?0.98], p < .001). However, no significant effects of curcumin supplementation on body weight were found. These results suggest that curcumin supplementation might have a positive effect on visceral fat and abdominal obesity that have been associated with NAFLD. 相似文献
90.
Hannes Hagström Patrik Nasr Mattias Ekstedt Stergios Kechagias Kristina Önnerhag Emma Nilsson 《Scandinavian journal of gastroenterology》2017,52(2):159-165
Background and aim: Moderate alcohol consumption has been associated with a lower risk of disease severity in non-alcoholic fatty liver disease (NAFLD). It is unclear if this reflects current or lifetime drinking, or can be attributed to confounders such as diet and exercise. We evaluated the impact of lifetime alcohol consumption on fibrosis severity in NAFLD.Methods: We prospectively enrolled 120 subjects with biopsy-proven NAFLD and through detailed questionnaires examined lifetime alcohol consumption, diet and physical activity. Main outcome measures were odds ratios (OR) for fibrosis stage, calculated through ordinal regression after adjustment for body mass index, diabetes mellitus type 2, smoking and age at biopsy. A biomarker for recent alcohol consumption, phosphatidyl ethanol (PEth) was sampled.Results: An increase in median weekly alcohol consumption to a maximum of 13 drinks per week was associated with lower fibrosis stage (adjusted OR for each incremental unit, 0.86; 95% CI, 0.76–0.97; p?=?.017). The lowest risk for fibrosis was found with the lowes`t odds seen in the top quartile of alcohol consumption (aOR 0.23; 95% CI 0.08–0.66; p?=?.006). Adding soft drink and coffee consumptions, and physical activity to the model did not change the estimates. Subjects with PEth ≥0.3?μmol/L had higher ORs for a higher fibrosis stage (aOR 2.77; 95% CI 1.01–7.59; p?=?.047).Conclusion: Lifetime alcohol consumption with up to 13 units per week is associated with lower fibrosis stage in NAFLD. Elevated PEth is associated with higher stages of fibrosis. 相似文献